CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens

Targeting cytotoxic T lymphocytes (CTLs), as chimeric antigen T cells (CAR-T), T cell receptor-engineered (TCR)-T cells or adoptive cell transfer of tumor infiltrating T cells (TILs) to solid tumors is a major therapeutic challenge. We describe a new strategy to confer these lymphocytes with de novo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara W. Feigelson, Tali Dadosh, Nehora Levi, Anita Sapoznikov, Hadas Weinstein-Marom, Dayana Blokon-Kogan, Yahel Avraham, Tamar Unger, Gideon Gross, Rony Dahan, Ronen Alon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Immunology
Subjects:	cancer immunotherapy tumor microenvironment cytotoxic lymphocytes adoptive cell therapy Fc receptors microvilli
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1398757/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens

Similar Items